Revenue from operations declined 20.9% year on year to Rs 592.90 crore in the quarter ended 30 June 2022. Profit before tax in Q1 FY23 stood at Rs 43.39 crore, up 83.9% from Rs 268.73 crore recorded in Q1 FY22. Total expenditure declined 12.5% YoY to Rs 431.20 crore during the quarter. Cost of materials consumed skid 4.5% to Rs 90.23 crore and employee benefits expenses slipped 2.3% to Rs 92.20 crore in Q1 FY23 over Q1 FY22. Pfizer is a research-based global biopharmaceutical company which is engaged in the discovery, development and manufacture of healthcare products. Shares of Pfizer closed 0.72% lower to end at Rs 4,230 on the BSE. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.